Meeting
2017 Genitourinary Cancers Symposium
Does higher number of lymph nodes (LNs) excised during radical prostatectomy (RP) improve biochemical relapse-free survival (bRFS) in patients with pT2-3a/pN0 prostate cancer?
Authors
Steven Neema Seyedin
University of Iowa Hospital and Clinics, Department of Radiation Oncology, Iowa City, IA
Steven Neema Seyedin , Darrion L Mitchell , James Kyle Russo , Sarah L Mott , Jessica Parkhurst , Mark C Smith , John Michael Buatti , John Morgan Watkins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 61)
DOI
10.1200/JCO.2017.35.6_suppl.61
Abstract #
61
Poster Bd #
C24
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Association of high CD8+ tumor infiltrating lymphocytes at prostatectomy with improved survival of prostate cancer patients.
First Author: Yuanquan Yang
Poster
2014 Genitourinary Cancers Symposium
A closer look at extraprostatic extension (EPE): Evaluation of PSA relapse rates following prostatectomy (RP) for pT3aN0 prostate cancer with or without margin involvement.
First Author: John Morgan Watkins
Poster
2023 ASCO Genitourinary Cancers Symposium
Length and Gleason pattern at positive surgical margin after radical prostatectomy to assess risk of postoperative recurrence in localized prostate cancer.
First Author: Masashi Kato
Poster
2023 ASCO Genitourinary Cancers Symposium
Validation of baseline health-related quality of life as prognostic indicator for survival outcome in men with intermediate risk prostate cancer undergoing radical prostatectomy.
First Author: Thilo Westhofen